MECHANISM OF IMMUNOTHERAPEUTIC ACTIVITY OF OK-432 IN THE TREATMENT OF PERITONEAL CARCINOMATOSIS

被引：2

作者：

FUKUI, H

REYNOLDS, CW

LENZ, B

SCHNEIDER, M

TALMADGE, JE

机构：

[1] CHUGAI PHARMACEUT CO, SHIZUOKA 412, JAPAN

[2] NCI, FREDERICK CANC RES FACIL, EXPTL IMMUNOL LAB, FREDERICK, MD 21701 USA

[3] NCI, FREDERICK CANC RES FACIL, PRECLIN SCREENING LAB, FREDERICK, MD 21701 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 6

页数：6

共 36 条

[31]

2-D

[32]

UCHIDA A, 1984, CANCER IMMUNOL IMMUN, V18, P5

[33]

UCHIDA A, 1983, INT J CANCER, V31, P1, DOI 10.1002/ijc.2910310102

[34]

UJIIE T, 1987, JPN J EXP MED, V57, P103

[35]

Vinzenz K, 1987, Cancer Detect Prev Suppl, V1, P463

YAMAMOTO, A ;

NAGAMUTA, M ;

USAMI, H ;

SUGAWARA, Y ;

WATANABE, N ;

NIITSU, Y ;

URUSHIZAKI, I .

IMMUNOPHARMACOLOGY, 1986, 11 (02) :79-86